Search Results - "BROUN, E. R"

Longitudinal Study of Adaptation to the Stress of Bone Marrow Transplantation by FIFE, B. L, HUSTER, G. A, CORNETTA, K. G, KENNEDY, V. N, AKARD, L. P, BROUN, E. R

“…This prospective longitudinal study of adaptation to bone marrow transplantation (BMT) addressed three questions: (1) When during BMT do individuals experience…”
Get full text

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy by EISEN, D, ESSELL, J, BROUN, E. R, SIGMUND, D, DEVOE, M

“…Oral acyclovir has been demonstrated to prevent reactivation of herpes simplex virus (HSV) infections when administered prophylactically to autologous bone…”
Get full text

Growth Characteristics and Expansion of Human Umbilical Cord Blood and Estimation of Its Potential for Transplantation in Adults by Broxmeyer, Hal E., Hangoc, Giao, Cooper, Scott, Ribeiro, Raul C., Graves, Vicki, Yoder, Mervin, Wagner, John, Vadhan-Raj, Saroj, Benninger, Lisa, Rubinstein, Pablo, Broun, E. Randolph

“…We estimated whether single collections of cord blood contained sufficient cells for hematopoietic engraftment of adults by evaluating numbers of cord blood…”
Get full text

Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer by Broun, E. Randolph, Nichols, Craig R., Gize, Gary, Cornetta, Kenneth, Hromas, Robert A., Schacht, Brenda, Einhorn, Lawrence H.

“…BACKGROUND The purpose of this study was to evaluate the use of two cycles of high dose chemotherapy with autologous bone marrow transplantation (ABMT) in the…”
Get full text

Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer : the University of Michigan experience and literature review by AYASH, L. J, CLARKE, M, SILVER, S. M, BRAUN, T, UBERTI, J, RATANATHARATHORN, V, REYNOLDS, C, FERRARA, J, BROUN, E. R, ADAMS, P. T

“…Testicular cancer patients refractory or in relapse after primary chemotherapy have < or =25% 5-year progression-free survival with salvage. To improve…”
Get full text

Recombinant methionyl human stem cell factor and Filgrastim for peripheral blood progenitor cell mobilization and transplantation in non Hodgkin's lymphoma patients : Results of a phase I/II trial by MOSKOWITZ, C. H, STIFF, P, JELACA-MAXWELL, K, NICHOLS, C. R, BROWN, S. L, NIMER, S. D, GABRILOVE, J, GORDON, M. S, MCNIECE, I, HO, A. D, COSTA, J. J, BROUN, E. R, BAYER, R. A, WYRES, M, HILL, J

“…To examine the safety and efficacy of recombinant-methionyl human stem cell factor (r-metHuSCF), 38 patients with intermediate-grade or immunoblastic…”
Get full text

Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation by BROUN, E. R, WHEAT, J. L, KNEEBONE, P. H, SUNDBLAD, K, HROMAS, R. A, TRICOT, G

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Tandem autotransplantation for the treatment of metastatic breast cancer by Broun, E R, Sridhara, R, Sledge, G W, Loesch, D, Kneebone, P H, Hanna, M, Hromas, R, Cornetta, K, Einhorn, L H

“…To investigate the tolerability and impact on progression-free and overall survival of two consecutive cycles of high-dose chemotherapy (HDC) with autologous…”
Get more information

Rapid engraftment after allogeneic transplantation using CD34-enriched marrow cells by CORNETTA, K, GHARPURE, V, GONIN, R, KUNKEL, L. K, OLDHAM, F, SROUR, E. F, MILLS, B, HROMAS, R, ABONOUR, R, BROUN, E. R, TRAYCOFF, C. M, HANNA, M, WYMAN, N, DANIELSON, C

“…Bone marrow cells expressing the surface antigen CD34 comprise approximately 1% of harvested marrow and are highly enriched for marrow progenitor cells,…”
Get full text

Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors by Broun, E R, Nichols, C R, Einhorn, L H, Tricot, G J

“…The authors reported their experience with the use of high-dose chemotherapy and autologous bone marrow rescue (ABMR) as salvage therapy in the treatment of…”
Get more information

Oral cavity complications of bone marrow transplantation by Eisen, D, Essell, J, Broun, E R

“…Bone marrow transplantation, once regarded as experimental, has evolved into a standard treatment for a variety of malignancies. Considerable advances have…”
Get more information

Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors by Broun, E R, Nichols, C R, Mandanas, R, Salzman, D, Turns, M, Hromas, R, Cornetta, K, Einhorn, L H

“…Thirty-three patients with germ cell cancer (GCT) recurrent after two cisplatin-based regimens or cisplatin refractory (progression within 4 weeks of the last…”
Get more information

High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors by Broun, E R, Nichols, C R, Tricot, G, Loehrer, P J, Williams, S D, Einhorn, L H

“…We report seven patients with germ cell tumors which either recurred following a minimum of two regimens of platinum-based chemotherapy or were refractory to…”
Get more information

Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support by Broun, E R, Nichols, C R, Turns, M, Williams, S D, Loehrer, P J, Roth, B J, Lazarus, H M, Einhorn, L H

“…Patients with relapsed germ cell cancer (GCT) have a poor prognosis when treated solely with conventional chemotherapy; high dose chemotherapy with autologous…”
Get more information

Minimizing graft rejection in allogeneic T cell-depleted bone marrow transplantation by Rigden, J P, Cornetta, K, Srour, E F, Hanna, M, Broun, E R, Hromas, R, Baute, J, Hilton, J, Cox, E, Rubin, L, Gonin, R, Tricot, G

“…Between October 1991 and May 1994, 42 patients were treated with cyclophosphamide, thiotepa, and total body irradiation followed by an allogeneic…”
Get more information

Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation by Hromas, R, Clark, C, Blanke, C, Tricot, G, Cornetta, K, Hedderman, A, Broun, E R

Get more information

A phase II trial of edatrexate in previously treated ovarian cancer. A Gynecologic Oncology Group study by Broun, E R, Iseminger, K A, Bookman, M

“…Twenty-two patients with recurrent ovarian cancer were entered into a Phase II trial of edatrexate at a dose of 80 mg/m2 i.v. weekly for five consecutive…”
Get more information

High-dose carboplatin and mitoxantrone with autologous bone marrow support in the treatment of advanced breast cancer by Broun, E R, Sledge, G W, Einhorn, L H, Tricot, G J

“…Ten patients with Stage II (four) and Stage IV (six) breast cancer were enrolled in a trial of conventional-dose induction therapy followed by high-dose…”
Get more information

Treatment of refractory lymphoma with high dose cytarabine, cyclophosphamide and either TBI or VP-16 followed by autologous bone marrow transplantation by Broun, E R, Tricot, G, Akard, L, Nichols, C, Cheerva, A, Jansen, J

“…This study was designed to test the efficacy and toxicity of combining high-dose cytarabine (3 g/m2 every 12 h x 8 doses day -7 to day -4, total dose 24 g/m2),…”
Get more information

Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation [letter] by Hromas, R, Cornetta, K, Srour, E, Blanke, C, Broun, ER

Get full text